Senseonics (NYSE:SENS) Shares Gap Up – Here’s Why

Senseonics Holdings, Inc. (NYSE:SENS)’s share price gapped up before the market opened on Thursday . The stock had previously closed at $1.17, but opened at $1.23. Senseonics shares last traded at $1.29, with a volume of 5,848,861 shares trading hands.

Analysts Set New Price Targets

A number of research firms recently commented on SENS. HC Wainwright reaffirmed a “buy” rating and set a $2.00 target price on shares of Senseonics in a report on Friday, November 15th. StockNews.com started coverage on shares of Senseonics in a research note on Thursday, December 26th. They set a “sell” rating for the company.

Senseonics Price Performance

The firm has a market cap of $794.77 million, a PE ratio of -10.27 and a beta of 0.69. The stock has a 50 day simple moving average of $0.69 and a two-hundred day simple moving average of $0.47. The company has a debt-to-equity ratio of 59.17, a quick ratio of 2.38 and a current ratio of 2.47.

Insider Buying and Selling at Senseonics

In other Senseonics news, CFO Frederick T. Sullivan bought 124,933 shares of the company’s stock in a transaction dated Thursday, December 12th. The shares were purchased at an average cost of $0.38 per share, for a total transaction of $47,474.54. Following the transaction, the chief financial officer now directly owns 2,478,844 shares of the company’s stock, valued at approximately $941,960.72. The trade was a 5.31 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Timothy T. Goodnow acquired 315,000 shares of the business’s stock in a transaction dated Tuesday, December 10th. The stock was acquired at an average price of $0.31 per share, with a total value of $97,650.00. Following the completion of the transaction, the chief executive officer now directly owns 11,310,355 shares of the company’s stock, valued at approximately $3,506,210.05. This represents a 2.86 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 3.60% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Senseonics

A number of large investors have recently added to or reduced their stakes in the stock. Renaissance Technologies LLC acquired a new stake in Senseonics in the 4th quarter worth about $720,000. Geode Capital Management LLC increased its position in shares of Senseonics by 9.7% during the fourth quarter. Geode Capital Management LLC now owns 6,405,100 shares of the company’s stock worth $3,354,000 after purchasing an additional 566,704 shares in the last quarter. Virtu Financial LLC purchased a new stake in shares of Senseonics during the fourth quarter worth approximately $148,000. HighTower Advisors LLC purchased a new stake in shares of Senseonics during the fourth quarter worth approximately $32,000. Finally, Raymond James Financial Inc. acquired a new position in Senseonics in the 4th quarter valued at $26,000. 12.36% of the stock is currently owned by institutional investors and hedge funds.

Senseonics Company Profile

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.